Violich Capital Management, Inc. Biogen Inc. Transaction History

Violich Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 07, 2019	SELL	$216.71 - $338.96 $157,114 - $245,745	-725 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $186,702 - $222,509	725 New	725 $210,000
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $188,594 - $266,734	-725 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $203,833 - $239,025	725	725 $227,000

995

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Violich Capital Management, Inc. with notifications on news.